Sign In
Buy LIVN
$80.14
-0.91 (-1.12%)
At Close: Jul 31, 2026
Chevy Chase Trust Holdings Inc. Purchases New Position in LivaNova PLC (NASDAQ:LIVN)
10:16am, Wednesday, 18'th Mar 2020
Chevy Chase Trust Holdings Inc. purchased a new stake in shares of LivaNova PLC (NASDAQ:LIVN) in the 4th quarter, HoldingsChannel.com reports. The firm purchased 483 shares of the company’s stock, v
LivaNova PLC (NASDAQ:LIVN) Shares Acquired by ProShare Advisors LLC
10:08am, Tuesday, 17'th Mar 2020
ProShare Advisors LLC grew its position in LivaNova PLC (NASDAQ:LIVN) by 14.9% during the 4th quarter, according to its most recent filing with the Securities and Exchange Commission (SEC). The instit
LivaNova PLC (NASDAQ:LIVN) Shares Sold by Panagora Asset Management Inc.
09:12am, Tuesday, 17'th Mar 2020
Panagora Asset Management Inc. lowered its position in LivaNova PLC (NASDAQ:LIVN) by 58.6% during the fourth quarter, according to its most recent 13F filing with the Securities and Exchange Commissio
LivaNova (NASDAQ:LIVN) Lowered to Hold at ValuEngine
06:26am, Tuesday, 17'th Mar 2020
LivaNova (NASDAQ:LIVN) was downgraded by research analysts at ValuEngine from a “buy” rating to a “hold” rating in a research report issued to clients and investors on Tuesday, ValuEngine repo
Bank of Montreal Can Grows Stock Position in LivaNova PLC (NASDAQ:LIVN)
09:06am, Saturday, 14'th Mar 2020
Bank of Montreal Can grew its holdings in shares of LivaNova PLC (NASDAQ:LIVN) by 63.5% in the 4th quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The fund
Outlook on Europe's Defibrillators Market to 2025 by Type, End-user and Region
10:38am, Friday, 13'th Mar 2020
Dublin, March 13, 2020 -- The "European Defibrillators Market 2019-2025" report has been added to ResearchAndMarkets.com's offering. European defibrillators.
LivaNova (NASDAQ:LIVN) Downgraded to Sell at BidaskClub
07:40am, Friday, 13'th Mar 2020
LivaNova (NASDAQ:LIVN) was downgraded by stock analysts at BidaskClub from a “hold” rating to a “sell” rating in a report released on Friday, BidAskClub reports. LIVN has been the subject of a
Highstreet Asset Management Inc. Acquires New Position in LivaNova PLC (NASDAQ:LIVN)
10:50am, Thursday, 12'th Mar 2020
Highstreet Asset Management Inc. acquired a new stake in shares of LivaNova PLC (NASDAQ:LIVN) during the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange C
Pune, March 12, 2020 -- The global cardiovascular devices market size is prognosticated to reach USD 82.20 billion by 2026 on account of the increasing cases of cardiovascular.
Key Companies Covered in the Cardiovascular Devices Market Research Report are Terumo Cardiovascular Systems Corporation, Siemens Healthcare GmbH, B. Braun Melsungen AG, Johnson & Johnson Services, In
Resumen: El sistema de terapia VNS de LivaNova, Symmetry, obtiene el marcado CE para la depresin difcil de tratar
01:38pm, Tuesday, 10'th Mar 2020
LivaNova PLC (NASDAQ:LIVN), una compañía de tecnología e innovación médica líder en el mercado, ha anunciado hoy que su sistema de terapia de estimula
Franklin Resources Inc. Purchases 97,159 Shares of LivaNova PLC (NASDAQ:LIVN)
12:20pm, Tuesday, 10'th Mar 2020
Franklin Resources Inc. raised its position in shares of LivaNova PLC (NASDAQ:LIVN) by 3.0% in the fourth quarter, according to the company in its most recent filing with the Securities & Exchange Com
Symmetry, das LivaNova VNS Therapy-System fr schwer zu behandelnde Depressionen, erhlt CE-Prfzeichen
10:18am, Tuesday, 10'th Mar 2020
LivaNova PLC (NASDAQ:LIVN), ein marktführendes medizintechnisches Innovationsunternehmen, gab heute bekannt, dass sein System Vagus Nerve Stimulation
LivaNova (NASDAQ:LIVN) Shares Down 6.4%
09:44am, Tuesday, 10'th Mar 2020
LivaNova PLC (NASDAQ:LIVN)’s stock price traded down 6.4% during trading on Monday . The stock traded as low as $65.60 and last traded at $67.91, 543,532 shares traded hands during trading. An incre
Le systme de thrapie VNS dvelopp par LivaNova, Symmetry, obtient le marquage CE pour la dpression rsistante au traitement
05:55am, Tuesday, 10'th Mar 2020
LivaNova PLC (NASDAQ : LIVN), une société leader dans le domaine des technologies médicales et de l’innovation, a annoncé aujourd’hui que son Système
